Es gab 50 kürzliche Insider-Transaktionen für Astria Therapeutics, Inc. (ATXS), darunter 45 Käufe und 4 Verkäufe. Die gesamten Insider-Käufe beliefen sich auf $85.92M und die gesamten Insider-Verkäufe auf $1.05M.
Bedeutende Insider mit kürzlicher Aktivität umfassen Kishbauch Michael D, Bate Kenneth, Lapointe Anthony Gregg. Insider-Transaktionen können Einblicke geben, wie die Unternehmensführung die Bewertung und Zukunftsaussichten der Aktie einschätzt.
Insider-Transaktionen — ATXS
| Datum |
Name |
Funktion |
Transaktionsart |
Aktien |
Ø Preis |
Wert |
Gehaltene Aktien |
| 2025-06-11 |
Kishbauch Michael D |
Director |
RSU-Zuteilung |
26,550 |
$5.79 |
$153.72K |
26,550 |
| 2025-06-11 |
Bate Kenneth |
Director |
RSU-Zuteilung |
26,550 |
$5.79 |
$153.72K |
26,550 |
| 2025-06-11 |
Lapointe Anthony Gregg |
Director |
RSU-Zuteilung |
26,550 |
$5.79 |
$153.72K |
26,550 |
| 2025-06-11 |
Cole Hugh M |
Director |
RSU-Zuteilung |
26,550 |
$5.79 |
$153.72K |
26,550 |
| 2025-06-11 |
Agarwal Sunil |
Director |
RSU-Zuteilung |
26,550 |
$5.79 |
$153.72K |
26,550 |
| 2025-06-11 |
Violin Jonathan |
Director |
RSU-Zuteilung |
26,550 |
$5.79 |
$153.72K |
26,550 |
| 2025-06-11 |
Beck Joanne T. |
Director |
RSU-Zuteilung |
26,550 |
$5.79 |
$153.72K |
26,550 |
| 2025-06-11 |
Callori Fred |
Director |
RSU-Zuteilung |
26,550 |
$5.79 |
$153.72K |
26,550 |
| 2025-03-21 |
Milne Jill C. |
CEO and President |
RSU-Zuteilung |
761,000 |
$6.41 |
$4.88M |
761,000 |
| 2025-03-21 |
Harshbarger Benjamin |
Chief Legal Officer |
RSU-Zuteilung |
262,500 |
$6.41 |
$1.68M |
262,500 |
| 2025-03-21 |
Komjathy Andrew |
Chief Commercial Officer |
RSU-Zuteilung |
225,000 |
$6.41 |
$1.44M |
225,000 |
| 2025-03-21 |
Clauser Noah |
Chief Financial Officer |
RSU-Zuteilung |
262,500 |
$6.41 |
$1.68M |
262,500 |
| 2025-03-21 |
Morabito Christopher |
Chief Medical Officer |
RSU-Zuteilung |
262,500 |
$6.41 |
$1.68M |
262,500 |
| 2025-03-21 |
Matthews Andrea |
Chief Business Officer |
RSU-Zuteilung |
262,500 |
$6.41 |
$1.68M |
262,500 |
| 2024-06-05 |
Kishbauch Michael D |
Director |
RSU-Zuteilung |
14,100 |
$9.18 |
$129.44K |
14,100 |
| 2024-06-05 |
Bate Kenneth |
Director |
RSU-Zuteilung |
14,100 |
$9.18 |
$129.44K |
14,100 |
| 2024-06-05 |
Lapointe Anthony Gregg |
Director |
RSU-Zuteilung |
14,100 |
$9.18 |
$129.44K |
14,100 |
| 2024-06-05 |
Cole Hugh M |
Director |
RSU-Zuteilung |
14,100 |
$9.18 |
$129.44K |
14,100 |
| 2024-06-05 |
Violin Jonathan |
Director |
RSU-Zuteilung |
14,100 |
$9.18 |
$129.44K |
14,100 |
| 2024-06-05 |
Beck Joanne T. |
Director |
RSU-Zuteilung |
14,100 |
$9.18 |
$129.44K |
14,100 |
| 2024-06-05 |
Callori Fred |
Director |
RSU-Zuteilung |
14,100 |
$9.18 |
$129.44K |
14,100 |
| 2024-04-08 |
Agarwal Sunil |
Director |
RSU-Zuteilung |
28,200 |
$11.40 |
$321.48K |
28,200 |
| 2024-04-05 |
Agarwal Sunil |
Director |
Unbekannt |
- |
- |
- |
- |
| 2024-04-01 |
Morabito Christopher |
Chief Medical Officer |
Informierter Verkauf |
10,000 |
$13.59 |
$135.94K |
- |
| 2024-02-08 |
Milne Jill C. |
CEO and President |
RSU-Zuteilung |
534,600 |
$15.26 |
$8.16M |
534,600 |
| 2024-02-08 |
Harshbarger Benjamin |
Chief Legal Officer |
RSU-Zuteilung |
175,000 |
$15.26 |
$2.67M |
175,000 |
| 2024-02-08 |
Komjathy Andrew |
Chief Commercial Officer |
RSU-Zuteilung |
175,000 |
$15.26 |
$2.67M |
175,000 |
| 2024-02-08 |
Clauser Noah |
Chief Financial Officer |
RSU-Zuteilung |
175,000 |
$15.26 |
$2.67M |
175,000 |
| 2024-02-08 |
Morabito Christopher |
Chief Medical Officer |
RSU-Zuteilung |
175,000 |
$15.26 |
$2.67M |
175,000 |
| 2024-02-08 |
Matthews Andrea |
Chief Business Officer |
RSU-Zuteilung |
175,000 |
$15.26 |
$2.67M |
175,000 |
| 2024-02-01 |
Perceptive Advisors Llc |
Director |
Informierter Kauf |
2,481,350 |
$12.09 |
$30M |
4,873,721 |
| 2024-01-29 |
Morabito Christopher |
Chief Medical Officer |
Informierter Verkauf |
9,200 |
$11.15 |
$102.55K |
- |
| 2024-01-26 |
Morabito Christopher |
Chief Medical Officer |
Informierter Verkauf |
800 |
$11.02 |
$8.81K |
- |
| 2023-12-21 |
Perceptive Advisors Llc |
Director |
Informierter Kauf |
740,000 |
$6.20 |
$4.59M |
2,392,371 |
| 2023-10-16 |
Perceptive Advisors Llc |
Director |
Informierter Kauf |
460,546 |
$8.03 |
$3.7M |
345,409 |
| 2023-06-02 |
Kishbauch Michael D |
Director |
RSU-Zuteilung |
14,100 |
$11.35 |
$160.04K |
14,100 |
| 2023-06-02 |
Bate Kenneth |
Director |
RSU-Zuteilung |
14,100 |
$11.35 |
$160.04K |
14,100 |
| 2023-06-02 |
Lapointe Anthony Gregg |
Director |
RSU-Zuteilung |
14,100 |
$11.35 |
$160.04K |
14,100 |
| 2023-06-02 |
Cole Hugh M |
Director |
RSU-Zuteilung |
14,100 |
$11.35 |
$160.04K |
14,100 |
| 2023-06-02 |
Milne Jill C. |
CEO and President |
RSU-Zuteilung |
275,000 |
$13.36 |
$3.67M |
275,000 |
| 2023-06-02 |
Harshbarger Benjamin |
Chief Legal Officer |
RSU-Zuteilung |
90,000 |
$13.36 |
$1.2M |
90,000 |
| 2023-06-02 |
Violin Jonathan |
Director |
RSU-Zuteilung |
14,100 |
$11.35 |
$160.04K |
14,100 |
| 2023-06-02 |
Beck Joanne T. |
Director |
RSU-Zuteilung |
14,100 |
$11.35 |
$160.04K |
14,100 |
| 2023-06-02 |
Komjathy Andrew |
Chief Commercial Officer |
RSU-Zuteilung |
80,000 |
$13.36 |
$1.07M |
80,000 |
| 2023-06-02 |
Clauser Noah |
Chief Financial Officer |
RSU-Zuteilung |
100,000 |
$13.36 |
$1.34M |
100,000 |
| 2023-06-02 |
Callori Fred |
Director |
RSU-Zuteilung |
14,100 |
$11.35 |
$160.04K |
14,100 |
| 2023-06-02 |
Morabito Christopher |
Chief Medical Officer |
RSU-Zuteilung |
90,000 |
$13.36 |
$1.2M |
90,000 |
| 2023-06-02 |
Matthews Andrea |
Chief Business Officer |
RSU-Zuteilung |
60,000 |
$13.36 |
$801.6K |
60,000 |
| 2023-04-17 |
Matthews Andrea |
Chief Business Officer |
Veräußerung |
60,000 |
$13.36 |
$801.6K |
- |
| 2023-04-17 |
Matthews Andrea |
Chief Business Officer |
RSU-Zuteilung |
20,000 |
$10.82 |
$216.4K |
20,000 |
■ Informativ — Transaktion am offenen Markt (bedeutendste)
■ Nicht-informativ (Kauf) — Vergütung, Optionsausübung, Wandlung
■ Nicht-informativ (Verkauf) — Quellensteuer, Verkauf bei Vesting
■ Neutral — Schenkung, Treuhand, Verfall
